Literature DB >> 28161805

MATE-1 modulation by kinin B1 receptor enhances cisplatin efflux from renal cells.

Gabriel R Estrela1,2, Frederick Wasinski1,2, Raphael J F Felizardo2, Laura L Souza3, Niels O S Câmara4, Michael Bader3, Ronaldo C Araujo5,6.   

Abstract

Cisplatin is a drug widely used in chemotherapy that frequently causes severe renal dysfunction. Organic transporters have an important role to control the absorption and excretion of cisplatin in renal cells. Deletion and blockage of kinin B1 receptor has already been show to protect against cisplatin-induced acute kidney injury. To test whether it exerts its protective function by modulating the organic transporters in kidney, we studied kinin B1 receptor knockout mice and treatment with a receptor antagonist at basal state and in presence of cisplatin. Cisplatin administration caused downregulation of renal organic transporters; in B1 receptor knockout mice, this downregulation of organic transporters in kidney was absent; and treatment by a B1 receptor antagonist attenuated the downregulation of the transporter MATE-1. Moreover, kinin B1 receptor deletion and blockage at basal state resulted in higher renal expression of MATE-1. Moreover we observed that kinin B1 receptor deletion and blockage result in less accumulation of platinum in renal tissue. Thus, we propose that B1 receptor deletion and blockage protect the kidney from cisplatin-induced acute kidney injury by upregulating the expression of MATE-1, thereby increasing the efflux of cisplatin from renal cells.

Entities:  

Keywords:  Cisplatin nephrotoxicity; Kinins; Organic transporters

Mesh:

Substances:

Year:  2017        PMID: 28161805     DOI: 10.1007/s11010-016-2920-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

1.  A human transporter protein that mediates the final excretion step for toxic organic cations.

Authors:  Masato Otsuka; Takuya Matsumoto; Riyo Morimoto; Shigeo Arioka; Hiroshi Omote; Yoshinori Moriyama
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

Review 2.  Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney.

Authors:  Hideyuki Motohashi; Ken-ichi Inui
Journal:  AAPS J       Date:  2013-02-22       Impact factor: 4.009

Review 3.  Renal organic anion transporters (SLC22 family): expression, regulation, roles in toxicity, and impact on injury and disease.

Authors:  Li Wang; Douglas H Sweet
Journal:  AAPS J       Date:  2012-10-09       Impact factor: 4.009

Review 4.  Acute renal failure.

Authors:  R Thadhani; M Pascual; J V Bonventre
Journal:  N Engl J Med       Date:  1996-05-30       Impact factor: 91.245

Review 5.  Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.

Authors:  Anne T Nies; Hermann Koepsell; Katja Damme; Matthias Schwab
Journal:  Handb Exp Pharmacol       Date:  2011

6.  Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients.

Authors:  Giuliano Ciarimboli; Cynthia S Lancaster; Eberhard Schlatter; Ryan M Franke; Jason A Sprowl; Hermann Pavenstädt; Vivian Massmann; Denise Guckel; Ron H J Mathijssen; Wenjian Yang; Ching-Hon Pui; Mary V Relling; Edwin Herrmann; Alex Sparreboom
Journal:  Clin Cancer Res       Date:  2012-01-05       Impact factor: 12.531

Review 7.  Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.

Authors:  N Pabla; Z Dong
Journal:  Kidney Int       Date:  2008-02-13       Impact factor: 10.612

8.  Kinin B2 receptor deletion and blockage ameliorates cisplatin-induced acute renal injury.

Authors:  Gabriel R Estrela; Frederick Wasinski; Reury F Bacurau; Denise M A C Malheiros; Niels O S Câmara; Ronaldo C Araújo
Journal:  Int Immunopharmacol       Date:  2014-06-25       Impact factor: 4.932

9.  Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin.

Authors:  Masahiro Tsuda; Tomohiro Terada; Tomoyuki Mizuno; Toshiya Katsura; Jin Shimakura; Ken-ichi Inui
Journal:  Mol Pharmacol       Date:  2009-03-30       Impact factor: 4.436

10.  Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury.

Authors:  Takanobu Matsuzaki; Takafumi Morisaki; Wakako Sugimoto; Koji Yokoo; Daisuke Sato; Hiroshi Nonoguchi; Kimio Tomita; Tomohiro Terada; Ken-ichi Inui; Akinobu Hamada; Hideyuki Saito
Journal:  Drug Metab Dispos       Date:  2008-01-07       Impact factor: 3.922

View more
  10 in total

Review 1.  COUP-TFII in Kidneys, from Embryos to Sick Adults.

Authors:  Sumiyasu Ishii; Noriyuki Koibuchi
Journal:  Diagnostics (Basel)       Date:  2022-05-09

2.  Association of Urine Platinum With Acute Kidney Injury in Children Treated With Cisplatin for Cancer.

Authors:  Asaf Lebel; Hayton Chui; Kelly R McMahon; Yong Jin Lim; Joseph Macri; Stella Wang; Prasad Devarajan; Tom D Blydt-Hansen; Michael Zappitelli; Bradley L Urquhart
Journal:  J Clin Pharmacol       Date:  2021-04-15       Impact factor: 3.126

3.  Interaction of the New Monofunctional Anticancer Agent Phenanthriplatin With Transporters for Organic Cations.

Authors:  Anna Hucke; Ga Young Park; Oliver B Bauer; Georg Beyer; Christina Köppen; Dorothea Zeeh; Christoph A Wehe; Michael Sperling; Rita Schröter; Marta Kantauskaitè; Yohannes Hagos; Uwe Karst; Stephen J Lippard; Giuliano Ciarimboli
Journal:  Front Chem       Date:  2018-05-25       Impact factor: 5.221

Review 4.  Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury.

Authors:  Sara J Holditch; Carolyn N Brown; Andrew M Lombardi; Khoa N Nguyen; Charles L Edelstein
Journal:  Int J Mol Sci       Date:  2019-06-20       Impact factor: 5.923

5.  Angiotensin-Converting Enzyme Inhibitor Protects Against Cisplatin Nephrotoxicity by Modulating Kinin B1 Receptor Expression and Aminopeptidase P Activity in Mice.

Authors:  Gabriel R Estrela; Frederick Wasinski; Marcos F Gregnani; Leandro C Freitas-Lima; Adriano C Arruda; Rafael Leite Morais; Denise Mac Malheiros; Niels O S Camara; João Bosco Pesquero; Michael Bader; Carlos Castilho Barros; Ronaldo Carvalho Araújo
Journal:  Front Mol Biosci       Date:  2020-05-20

Review 6.  Cisplatin chemotherapy and renal function.

Authors:  Jie Zhang; Zhi-Wei Ye; Kenneth D Tew; Danyelle M Townsend
Journal:  Adv Cancer Res       Date:  2021-04-28       Impact factor: 6.242

7.  Regulated cell death in cisplatin-induced AKI: relevance of myo-inositol metabolism.

Authors:  Fei Deng; Xiaoping Zheng; Isha Sharma; Yingbo Dai; Yinhuai Wang; Yashpal S Kanwar
Journal:  Am J Physiol Renal Physiol       Date:  2021-02-22

8.  PPARα-Dependent Modulation by Metformin of the Expression of OCT-2 and MATE-1 in the Kidney of Mice.

Authors:  Adriano Cleis Arruda; Mauro Sérgio Perilhão; Warley Almeida Santos; Marcos Fernandes Gregnani; Alexandre Budu; José Cesar Rosa Neto; Gabriel Rufino Estrela; Ronaldo Carvalho Araujo
Journal:  Molecules       Date:  2020-01-17       Impact factor: 4.411

Review 9.  The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity.

Authors:  Daniela Maria Tanase; Evelina Maria Gosav; Smaranda Radu; Claudia Florida Costea; Manuela Ciocoiu; Alexandru Carauleanu; Cristina Mihaela Lacatusu; Minela Aida Maranduca; Mariana Floria; Ciprian Rezus
Journal:  Int J Mol Sci       Date:  2019-10-22       Impact factor: 5.923

10.  PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2.

Authors:  Leandro Ceotto Freitas-Lima; Alexandre Budu; Adriano Cleis Arruda; Mauro Sérgio Perilhão; Jonatan Barrera-Chimal; Ronaldo Carvalho Araujo; Gabriel Rufino Estrela
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.